Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: A histometric study in rats

Journal of Applied Oral Science

Volumn 18, Issue 6, 2010, Pages 630-634

  Fracon, Ricardo Nogueira ^a   Teófilo, Juliana Mazzonetto ^a   Moris, Lzabela Cristina ^a   Lamano, Teresa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone regeneration; Cyclooxygenase 1; Cyclooxygenase 1 inhibitors; Cyclooxygenase 2; Cyclooxygenase 2 inhibitors; Ketorolac; Paracetamol

Indexed keywords

EID: 79551566670     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/S1678-77572010000600016     Document Type: Article

References (30)

1. Azoubel MC, Menezes AM, Bezerra D, Oriá RB, Ribeiro RA, Brito GA. Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats. Braz J Med Biol Res. 2007;40:117-25.
2. Baratieri A, Deli R. The effect on bone repair of aspirin cones placed in extraction sockets in dogs: a histopathologic study. J Oral Pathol. 1979;8:198-206.
3. Battisti N. The evaluation of the analgesic and anti-inflammatory effects of flurbiprofen mouthwash and 100-mg tablets in oral medicine. Minerva Stomatol. 1994;43:141-4.
4. Bailey BM, Zaki G, Rotman H, Woodwards R. A double-blind comparative study of soluble aspirin and diclofenac dispersible in the control of postextraction pain after removal of impacted third molars. Int J Oral Maxillofac Surg. 1993;22:238-41.
5. Bergenstock M, Min W, Simon AM, Sabatino C, O'Connor JP. A comparison between the effects of acetaminophen and celecoxib on bone fracture healing in rats. J Orthop Trauma. 2005;19:717-23.
6. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12:250-75.
7. Carvalho TL, Bombonato KF, Brentegani LG. Histometric analysis of rat alveolar wound healing. Braz Dent J. 1997;8:9-12.
8. Elsubeihi ES, Heersche JN. Quantitative assessment of post- extraction healing and alveolar ridge remodelling of the mandible in female rats. Arch Oral Biol. 2004;49:401-12.
9. Ferry ST, Dahners LE, Afshari HM, Weinhold PS. The effects of common anti-inflammatory drugs on the healing of rat patellar tendon. Am J Sports Med. 2007;35(8):1326-33.
10. Fracon RN, Teófilo JM, Satin RB, Lamano T. Prostaglandins and bone: potential risks and benefits related to the use of nonsteroidal anti-inflammatory drugs in clinical dentistry. J Oral Sci. 2008;50:247-52.
11. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, Cullinane DM, Krall EA, Fitch JL, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg. 2007;89:114-25.
12. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12:46-55.
13. Guglielmotti MB, Cabrini RL. Alveolar wound healing and ridge remodeling after tooth extraction in the rat: a histologic, radiographic and histometric study. J Oral Maxillofac Surg. 1985;43:359-64.
14. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008;22:383-90.
15. Ho ML, Chanq JK, Wang GJ. Antiinflammatory drug effects on bone repair and remodeling in rabbits. Clin Orthop Relat Res. 1995;313:270-8.
16. Lamano Carvalho TL. Effect of conventional and COX-2 selective non-steroidal antiinflammatory drugs on bone healing. Acta Ortop Bras. 2007;15:166-8.
17. Lökken P, Olsen I, Bruaset I, Norman-Pedersen K. Bilateral surgical removal of impacted lower third molar teeth as a model for drug evaluation: a test with ibuprofen. Eur J Clin Pharmacol. 1975;8:209-16.
18. Mullis BH, Copland ST, Weinhold PS, Miclau T, Lester GE, Bos GD. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury 2006;37:827-37.
19. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by blockade of cannabinoid CB1 receptors. Eur J Pharmacol. 2006;531:280-81.
20. Parente L. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol. 2001;28:2375-32.
21. Patrignani P, Capone ML, Taconelli S. Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor. Expert Opin Pharmacoter. 2003;4:265-84.
22. Pountos I, Giannoudis PV, Jones E, English A, Churchman S, Field S, et al. NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis. J Cell Mol Med. 2010. Epub ahead of print.
23. Poveda Roda R, Bagán JV, Jiménez Soriano Y, Gallud Romero L. Use of nonsteroidal antiinflammatory drugs in dental practice. A review. Med Oral Patol Oral Cir Bucal. 2007;12(1):E10-8.
24. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon and ligament healing. Inflamm Res. 2005;54:358-66.
25. Rajakariar R, Yaqoob MM, Gilroy DW. COX-2 in inflammation and resolution. Mol Interv. 2006;6:199-207.
26. Rindeau D, Percival MD, Brideau C, Charleson S, Dube D, Ethier D, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther. 2001;296(2):558-66.
27. Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflamatory drugs. Proc Natl Acad Sci USA. 1999;96:3275-80.
28. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID- induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology. 2000;119:706-14.
29. Warner TD, Giuliano F, Voinovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96:7563-8.
30. Yugoshi LI, Sala MA, Brentegani LG, Lamano Carvalho TL. Histometric study of socket healing after tooth extraction in rats treated with diclofenac. Braz Dent J. 2002;13:92-6.